Danaher Corp. (DHR) Strikes Deal with Beckman Coulter (BEC)
Danaher Corp. (DHR), the designer and manufacturer of various medical, industrial, commercial, and consumer products, recently announced a deal with Beckman Coulter Inc., a biomedical testing instrument manufacturer, worth approximately $5.87 billion. If the deal closes in June of this year as expected, Beckman Coulter will become a major component in Danaher’s life sciences and diagnostics department, making the life sciences unit the biggest department in the company. Danaher Corporation has reached an agreement to pay $85.30 per Beckman share, a 45% premium over the share price reported for Beckman back on December 9th, a day before the M&A news…